You can now choose between GLP-1 pills or shots for weight loss. Here's what you need to know to decide which one is best for ...
This new tablet promises to be even more convenient than its predecessor with similar, if slightly less drastic, ...
Consequently, the medical device industry has prioritized the creation of support mechanisms that simplify these processes. Modern needle aids utilize ergonomic structures to ensure that needles enter ...
The daily pill, called Foundayo, follows the approval of Novo Nordisk's Wegovy pill in recent months. The lowest dose is ...
The FDA approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity ...
Orforglipron is the second daily weight-loss pill to hit the market. The first was the Wegovy pill, from Novo Nordisk, which ...
The daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form ...
Butabika National Referral Mental Hospital has taken over a critical addiction treatment programme for people who inject drugs, following the withdrawal of donor funding that had sustained it since ...
Model estimates SUBLOCADE ® may reduce staff time and associated costs compared with other medications for opioid use disorder in jails and prisons ; RICHMOND, Va., March 31, 202 ...
European regulators recommended a subcutaneous formulation for a key anti-CD38 therapy, offering clinicians and patients more flexible administration options for multiple myeloma.
(1,2) "Awiqli (R) is an important new option that meets a real need as the first FDA-approved, once-weekly basal insulin for adult patients with type 2 diabetes. It's helping to reframe what basal ...
The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control blood sugar levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results